Carlsson A et al. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 2001; 41:237-260.
Cowan WM, Harter DH, and Kandel ER. The emergence of modern neuroscience: Some implications for neurology and psychiatry. Annu Rev Neurosci 2000; 23:343-391.
Cherubini E and Conti F. Generating diversity at GABAergic synapses. Trends Neurosci 2002;24:155-162.
Dunzendorfer S and Wiedermann CJ. Neuropeptides and the immune system: focus on dendritic cells. Crit Rev Immunol 2001;21:523-557.
Dautzenberg FM and Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 2002;23:71-78.
Hoyer D et al. International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 1994;46:157-203.
Law A, Gauthier S, and Quirion R. Say NO to
Leurs R, Watanabe T, and Timmerman H. Histamine receptors are finally "coming out." Trends Pharmacol Sci 2001;22:337-339.
Strange PG. Antipsychotic drugs: Importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 2001;53:119-133.
Yehuda S, Rabinovitz, S, Carasso RL, and Mostofsky DI. Fatty acids and brain peptides. Peptides 1998;19:407-419.
Was this article helpful?